NCT06870422View on ClinicalTrials.gov

To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

April 3, 2025

Study Completion Date

April 14, 2025

Conditions
Healthy
Interventions
DRUG

Esflurbiprofen Topical System

TK-254RX will be applied for one day

Trial Locations (1)

99084

SocraTec R&D GmbH Clinical Pharmacology Unit, Mainzerhofplatz

All Listed Sponsors
collaborator

SocraTec R&D GmbH

OTHER

collaborator

SocraMetrics GmbH

INDUSTRY

collaborator

HWI pharma services GmbH

INDUSTRY

lead

Teikoku Seiyaku Co., Ltd.

INDUSTRY

NCT06870422 - To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers. | Biotech Hunter | Biotech Hunter